| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Sanjay Gupta CEO | XNSE Exchange | Y8896L148 CUSIP |
| India Country | 17,059 Employees | 29 May 2026 Last Dividend | 8 Jul 2022 Last Split | - IPO Date |
Torrent Pharmaceuticals Limited is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacturing, and marketing of generic pharmaceutical formulations. With operations spanning across key markets such as India, the United States, Brazil, Germany, and other international territories, the company has established a significant global presence. Torrent Pharmaceuticals is renowned for its comprehensive product portfolio that caters to various therapeutic areas. Originally founded in 1959 and initially known as Trinity Laboratories, the company underwent a name change to Torrent Pharmaceuticals Limited in 1971. Based in Ahmedabad, India, it functions as a subsidiary of Torrent Investments Private Limited, marking its stature as a noteworthy entity in the pharmaceutical sector.
Torrent Pharmaceuticals Limited offers an extensive range of products and services across various therapeutic areas and specialties:
In addition to its extensive product line, Torrent Pharmaceuticals Limited extends its capabilities to provide contract manufacturing services, leveraging its expansive infrastructure and manufacturing excellence to collaborate with other firms in the pharmaceutical industry.